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SUMMARY 
To ensure that an animal in pain receives the correct analgesic treatment pain assessment is of 
great importance. Recent research has shown that horses change their facial expression during 
pain, and shows a so called pain face. Using pain face as a pain assessment tool in horses is 
only sparsely validated but is of great interest since studies in humans have shown that it is 
less possible to hide a pain face. The aim of this study was to investigate the clinical 
application of the equine pain face as a pain assessment tool during clinically relevant 
conditions. The hypothesis was that facial expression of pain in postoperative horses would 
disappear or diminish after analgesic treatment. The secondary aim of this study was to 
investigate the performance of the equine pain face as a pain assessment tool in postoperative 
horses.  
 
Eleven horses that underwent exploratory laparotomy due to colic and one horse that 
developed hemoperitoneum after castration were included in the study. The behaviour and 
face of the horses were filmed postoperatively at two occasions, before analgesic treatment 
and two hours after analgesic treatment. The randomised video films were shown to seven 
blinded observers, who pain scored each horse according to facial expression of pain (no pain 
face, pain face present or intense pain face) and a modified version of the Equine Pain Scale 
(EPS). 
 
Facial expression of pain was observed in all of the twelve horses included in the study. 
However, no significant difference was seen in grading of facial expression of pain or the 
score of the modified EPS before and after analgesic treatment. This indicates that either the 
analgesic treatment was not always optimized or that there could be several other conditions 
that contributed to the changes in the face mimic. Fleiss kappa for inter-observer reliability of 
facial expression of pain was determined to 0.11 (slight agreement). The low kappa value is 
most likely due to the subjective grading of facial expression of pain, concurrent or 
intermittent lidocaine and butorphanol treatment and differences in observers’ ability to 
evaluate facial expression. Investigations of the equine pain face regarding the number of 
present facial action units that are needed and a weighting of the facial action units is of great 
interest in order to create a higher inter-observer reliability. Intra-observer reliability was 
determined to a mean value of 0.51 (moderate agreement). Furthermore, five out of seven 
observers had a kappa value above 0.5, suggesting that facial expression of pain could be a 
good supplementary pain assessment tool when a single person observes a horse over a time.  
 
The score of the modified EPS was compared to the grading of facial expression of pain. The 
included horses were divided into three different groups on the basis of their total score of the 
modified EPS; group 1 (score of 0-3), group 2 (score of 4-7) and group 3 (score of 8-11). 
Sixty-three % of the horses in group 1 expressed a pain face and sixty % of the horses in 
group 2 expressed a pain face. Furthermore, hundred % of the horses in group 3 expressed a 
pain face. This study evaluated pain with a visceral component. Further studies regarding the 
specificity and sensitivity of facial expression of pain are required when complex pain types 
and medication are involved. 
 
SAMMANFATTNING 
  
För att kunna säkerställa att djur med smärta får en korrekt smärtbehandling är 
smärtbedömning särskilt viktigt. Nyligen publicerade studier visar att hästar uttrycker 
specifika ansiktsuttryck vid smärta, ett så kallat ”smärtansikte”. Användning av ansiktsuttryck 
vid smärtbedömning är ännu inte fullt validerat hos hästar, men det är mycket intressant 
eftersom studier på människor har visar att ett ”smärtansikte” inte kan döljas helt med viljan. 
Syftet med studien var att undersöka den kliniska applicerbarheten av hästens ”smärtansikte” 
som ett verktyg i smärtbedömning. Hypotesen var att ansiktsuttryck för smärta hos 
postoperativa hästar skulle försvinna eller avta efter smärtlindrande behandling. Studiens 
sekundära syfte var att undersöka pålitligheten och sensitiviteten av gradering av 
ansiktsuttryck för smärta hos postoperativa hästar. 
 
Elva hästar som genomgick explorativ laparatomi på grund av kolik samt en häst som 
utvecklade hemoperitoneum efter kastartion deltog i studien. Hästens beteende och ansikte 
filmades postoperativt vid två tillfällen, strax före och 2 timmar efter smärtlindrande 
behandling. Filmerna randominiserades och visades för 7 blindade observatörer, vilka 
smärtbedömde varje häst med hjälp av gradering av ”smärtansikte” (inget smärtansikte, 
smärtansikte närvarande och intensivt smärtansikte) och en modifierad version av ”the Equine 
Pain Scale” (EPS). 
  
Alla hästar i studien uttryckte ansiktsuttryck för smärta. Dock sågs ingen signifikant skillnad 
före och efter smärtlindrande behandling gällande gradering av ”smärtansikte” eller poäng i 
den modifierade versionen av EPS. Detta indikerar antingen att alla hästar inte var fullt 
smärlindrande eller att andra tillstånd än smärta orsakade förändringar i ansiktsuttrycken. 
Fleiss kappa-värde för pålitligheten mellan observatörer gällande gradering av ”smärtansikte” 
bestämdes till 0.11 (ringa överrensstämmelse). Det låga värdet beror troligtvis på att 
graderingen av ”smärtansiktet” var subjektiv, den fortlöpande eller intermittent behandlingen 
med lidokain och butorfanol och att det finns skillander i observatörers förmåga att bedöma 
ansiktsuttryck. För att höja pålitligheten mellan observatörer är det viktigt att undersöka hur 
många ansiktsdrag för smärta som måste ses för att säga att en häst har ont, samt vilka 
ansiktsuttryck som har störst betydelse för att indikera smärta hos hästar. Medelvärdet för 
pålitligheten inom varje observatör bestämdes till 0.51 (måttlig övverensstämmelse), där 5 av 
7 observatörer hade ett kappa-värde över 0.5. Detta indikerar att hästens ”smärtansikte” kan 
vara ett bra komplementärt verktyg då en enskild individ vill följa en hästs smärtnivå över en 
tid.  
 
En jämförelse gjordes mellan graderingen av ansiktsuttryck för smärta och poäng från den 
modifierade versionen av EPS. Hästarna delades in i tre olika grupper med hänsyn till deras 
poäng från den modifierade versionen av EPS; grupp 1 (poäng 0-3), grupp 2 (tpoäng 4-7) och 
grupp 3 (poäng 8-11). 63% av hästarna i grupp 1 uttryckte ett ”smärtansikte” och 60% av 
hästarna i grupp 2 uttryckte ett ”smärtansikte”. Vidare uttryckte 100% av hästarna i grupp 3 
ett ”smärtansikte”. Denna studien undersöker smärta som inkluderar viscerala komponenter. 
Ytterligare studier om specificitet och sensitivitet gällande hästens ansiktsuttryck för smärta 
vid komplexa smärttyper och medicinering krävs. 
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INTRODUCTION 
Animal pain is defined as “an aversive sensory experience caused by actual or potential injury 
that elicits protective motor and vegetative reactions, results in learned avoidance behaviour, 
and may modify species specific behaviour, including social behaviours” (Zimmermann, 
1986: see Rutherford, 2002 p. 31). Minimizing pain is of great animal ethical interest. 
Moreover, studies have shown that early and forceful pain control improve recovery, reduce 
catabolism and shorten the hospital stay (Yardeni et al., 2007; McGuire et al., 2006; Shavit et 
al., 2005; Sellon et al., 2004). Therefore it is important for animals in pain to receive a good 
analgesic treatment, with correct substance, dose and duration. To fulfil these requirements 
pain assessment is of great necessary.  
 
Several studies regarding animal pain assessment have been presented, but until a decade ago 
only a few of these studies related to pain assessment in horses. Scientists have made progress 
in this field during the last years and research is still going on. Nevertheless, no universal 
equine pain scale has yet been developed (Gleerup & Lindegaard, 2015). Horses (and other 
animals), in contrast to humans, are not able to communicate their pain experience in words to 
us. Consequently, the pain assessment relies on the observer’s ability to interpret 
physiological and behavioural indices, thereby collecting indirect evidence of pain (Price et 
al., 2003). Assessment of pain in horses is complicated further by the circumstance that 
horses are prey animals and may hide their responses to pain when humans are present. 
 
Recent research has shown that horses change their facial expression during pain, expressing 
a so called pain face (Gleerup et al., 2015; Dalla Costa et al., 2014). Facial expression of pain 
has earlier been described and used as a pain assessment tool in other animals such as mice 
(Langford et al., 2010), rats (Sotocinal et al., 2011) and rabbits (Keating et al., 2012). Using 
facial expression of pain as a pain assessment tool in horses is not validated but it is of great 
interest since studies in humans have shown that it is not possible to fully hide facial 
expression of pain (Prkachin & Mercer, 1989).  
 
The aim of this study is to investigate the clinical application of the equine pain face as a pain 
assessment tool. The hypothesis was that facial expression of pain in postoperative horses 
would disappear or diminish after analgesic treatment. The secondary aim of this study is to 
investigate the reliability and sensitivity of the equine pain face as a pain assessment tool in 
postoperative horses. 
 
 
LITERATURE REVIEW 
Pain physiology 
To be able to collect information about the environment and the organism itself, the body 
contains highly specialized primary afferents, called sensory fibres (Meyer et al., 2006). Some 
of the sensory fibres are selectively sensitive to different kind of stimuli (e.g. heat, cold and 
pressure). Furthermore, a group of sensory fibres have a relatively high threshold, only 
responding to intense noxious stimuli that could produce injury (intense thermal, chemical 
and mechanical stimuli), and therefore they are named nociceptors (Meyer et al., 2006). The 
nociceptors are found in most of the organs in the body and are highly present in the skin, 
2 
 
mucosa, cornea, eardrum and the dental pulp (Norrbrink & Lundeberg, 2014). Internal organs 
have more diffuse sensory innervations and most of the sensory fibres are found in the fascia 
surrounding the organs. The pain that originates from the internal organs is called visceral 
pain (Sjaastad et al., 2010). Furthermore, somatic pain originates from the skin (superficial 
somatic pain) or from the skeletal muscles, connective tissue, bones and joints (deep somatic 
pain).  
 
 
Figure 1. Combined sketch of signal pathway from the periphery all the way to the cortex. Only the 
pathway via the spinothalmic tract is shown due to simplification. By Bettina Guebeli (Own work) [CC 
BY-SA 4.0 (http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commonshttps. Available 
from: https://upload.wikimedia.org/wikipedia/commons/7/70/Sketch_colored_final.png  
 
The nociceptors can be subdivided regarding to the grade of myelinisation, type of activating 
stimuli, response characteristics and distinct chemical markers (Meyer et al., 2006). Literature 
often refers to two groups of nociceptors; A-delta-fibre nociceptors and C-fibre nociceptors 
(Norrbrink & Lundeberg, 2014). C-fibres are unmyelinated and therefore have a slow 
conduction velocity (< 2m/s), while A-delta-fibres, which are myelinated, have a faster 
conduction (> 2m/s) (Meyer et al., 2006). Therefore, the pain experience will depend on the 
fibres that are activated (Norrbrink & Lundeberg, 2014). Activation of A-delta-fibre 
nociceptors will cause a nerve impulse that conducts fast to the brain, where it will mostly be 
projected in the somatosensory cortex. This creates an instantaneous pain experience which is 
sharp, distinct and well localized. In contrast, a nerve impulse created by activation of C-fibre 
nociceptors will give a slower conduction and it will be projected more diffuse in the brain, 
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which creates a more widespread pain experience. The different kind of pain experiences can 
be illustrated by when a person accidently hit its toe on a piece of furniture. First the person 
will feel a sharp and distinct pain (conducted by A-delta-fibres) and a few seconds later a 
diffuse and aching pain occurs (conducted by C-fibres) (Norrbrink & Lundeberg, 2014).  
 
Activation on primary afferent nociceptors will result in signal conduction to the dorsal horn 
of the spinal cord (Todd & Koerber, 2006). In the dorsal horn the first synapse transmission of 
the signal occurs and glutamate is suggested to be the principal neurotransmitter. Synapses are 
formed with neurons located in the dorsal horn, including projections cells (with axons that 
travel to the brain and transport information to several parts in the brain) and interneurons 
(with axons that remain in the spinal cord). Interneurons can be divided into inhibitory and 
excitatory interneurons, however still little is known about their organization and function 
(Todd & Koerber, 2006). Pain is a complex experience, involving several different pathways 
when passing the pain signal from the spinal cord to the brain (Bushnell & Apkarian, 2006). 
This results in activation of multiple regions in the forebrain, which creates the pain 
experience. An overview of the nociceptive pathway is shown in figure 1. 
 
 
Pain classification 
There are several ways to classify pain; by time (acute, chronic), underlying cause 
(nociceptive, inflammatory, neuropathic, psychogenic or idiopathic) (Norrbrink & Lundeberg, 
2014) or from a neurobiological perspective (Woolf, 2010). When described from a 
neurobiological perspective, pain may be divided into three major groups; nociceptive pain, 
inflammatory pain and pathological pain.  
 
Nociceptive pain serves as an early warnings system for actual or potential injury (Woolf, 
2010). When the nociceptors are activated by intense noxious stimuli an action potential in 
passed to the spinal cord (Norrbrink & Lundeberg, 2014). In the spinal cord, some of the 
signals are directed by interneurons, further activating sympathetic and motor neurons. This 
activation of sympathetic neurons results in changes in the blood circulation in the skin, 
muscles and viscera and also affects the motility of the intestine and the bladder. Activation of 
motor neurons is a part of a defence mechanism, known as the reflex withdrawal (Norrbrink 
& Lundeberg, 2014). An example of reflex withdrawal is when a person removes the hand 
when accidently touching a hot object (Sjaastad et al., 2010). Signals are also passed from the 
spinal cord to the central nervous system (Norrbrink & Lundeberg, 2014).  
 
The second kind of pain is the inflammatory pain. Cardinal signs of inflammation are heat, 
swelling, redness, reduced function and pain. Tissue damage or infection causes release of 
inflammatory mediators, such as prostaglandins, cytokines, growth factors, and bradykinin. 
These inflammatory mediators can cause spontaneous pain by direct activation of the 
nociceptors but also act indirectly by stimulating the release of additional algogenic (pain 
inducing) agents from inflammatory cells (Cunha et al., 2005; Steranka et al., 1988). Steranka 
et al. (1988) showed that bradykinin acts as a strong algogenic agent on the nociceptors, while 
Cunha et al. (2005) showed that cytokines play an important role by activating a distinct 
sequence resulting in the release of prostanoids and sympathomimetic amines. The 
inflammatory mediators mentioned earlier not only act as algogenic agents but may also cause 
sensitization of the nociceptors (McMahon et al., 2006; Cunha et al., 2005; Burgess et al., 
4 
 
2000; Ferreira, 1972), which causes primary hyperalgesia. Primary hyperalgesia is 
characterized by a lowered nociceptor threshold for thermal and mechanical stimuli at the site 
of the injury (Hardy et al., 1950). Hyperalgesia plays an important role in inflammatory pain, 
preventing further damage and thereby promotes recovery of the lesion (Woolf, 2010). During 
the inflammatory state neuropeptides and neurotrophic factors such as substance P and brain-
derived neurotrophic factor (BDNF) are released from central terminals of the primary 
afferents (Woolf, 1983). By acting as co-transmitters they induce long-lasting changes in 
spinal excitability (Woolf, 1983). Central sensitization will create a pain experience of a 
bigger area than the actual injury, also called secondary hyperalgesia (Torebjörk et al., 1992).  
 
The third class of pain is the pathological pain. In contrast to nociceptive and inflammatory 
pain, which work adaptive and protective, pathological pain is suggested to be inadequate and 
nonprotective (Devor, 2006). Pathological pain resulting from abnormal function of the 
nervous system can be divided into two subclasses; neuropathic pain and dysfunctional pain 
(Woolf, 2010). Neuropathic pain is caused by damage or disease in the nervous system. The 
exact pathophysiological mechanisms causing neuropathic pain are not fully understood 
(Woolf, 2010). Injury of primary sensory neurons causes electrical hyperexcitability and 
abnormal impulse generation, referred as ectopic electrogenesis (Wall & Gutnick, 1974). Wall 
and Gutnick (1974) showed in their study that nerve injury created a steady ongoing stream of 
nerve impulses and also caused abnormal responsiveness of mechanical stimuli. Studies have 
shown that blocking of such ectopic discharges from entering the spinal cord results in 
absence of pain in neuropathic rats (Yoon et al., 1996; Sheen & Chung, 1993). A later study 
showed that the level of ectopic discharges is well correlated with pain behaviours in a rat 
neuropathic pain model, which further supports the theory that spontaneous ectopic 
discharges are an important mechanism related to neuropathic pain (Chul Han et al., 2000). 
Dysfunctional pain results from neither damage nor inflammation (Woolf, 2010). This type of 
pain is associated with clinical disorders such as fibromyalgia, irritable bowel syndrome, 
tension type headache, temporomandibular joint disease, interstitial cystitis ect. The 
mechanisms behind dysfunctional pain are still not fully understood, but a recent study 
reinforce earlier evidence that central sensitization and impaired endogenous modulation 
system are presented in patient with fibromyalgia, chronic daily headache and myofascial 
pain (Hilgenberg-Sydney et al., 2015).  
 
 
Pain assessment in horses 
Pain assessment in animals (including horses) is a value judgment relying on behavioural and 
physiological indices to provide indirect evidence of mental state (Molony & Kent, 1997), 
thereby relaying on the observers ability and experience. Several different factors influence 
the pain experience and expression, such as species, breed, individual variations, 
environmental characteristics and drugs (Flecknell, 2000: see Bussières et al., 2008 p. 294). 
Consequently, assessment of animal pain is highly species specific (Price et al., 2003), 
requiring research to be executed on the species of interest.  
 
 
Behavioural responses to pain 
Changes I behaviour may be the parameter most often used to assess animal pain (Rutherford, 
2002). It has been suggested that there are some general changes in behaviour regardless of 
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the type of pain, and some more specific behaviour related to specific diseases (Gleerup & 
Lindegaard, 2015; Ashley et al., 2005). Decreased weight bearing in horses has been recorded 
in horses with orthopaedic pain (Lindegaard et al., 2010; Bussières et al., 2008), and can be 
considered as an example of pain-specific behaviour. Moreover, pawing, flank watching and 
rolling is associated with horses with colic (Sutton et al., 2013; Graubner et al., 2011).  
 
Several different signs of lethargy, assumed to be more general symptoms of pain (Gleerup & 
Lindegaard, 2015; Ashley et al., 2005), have been recorded in postoperative horses. Horses 
with somatic postoperative pain have been shown to spend less time eating, exploring and 
moving, and more time positioned in the back of the stable, head positioned below withers 
and expressing pre-defined abnormal behaviours (abnormal standing, abnormal locomotion, 
abnormal oral activity) (Price et al., 2003). Another research supporting this results, suggested 
that reduced locomotion is a potential indicator of postoperative pain in horses (Pritchett et 
al., 2003). Horses that underwent exploratory laparotomy, thereby suffering from visceral and 
somatic pain, showed changes in their posture (including gross pain behaviours, changes in 
head position and ear position, location in the stable) and socialization (including less 
interactive behaviour when human approach and less response to grain offered). Pritchett et 
al. (2003) also showed that postoperative horses spent significantly more time expressing pain 
behaviour than control horses. Pain behaviours observed in this study were flank gesture, 
flehmen, kicking and stretching. Increased restlessness, also considered as general pain 
behaviour (Gleerup & Lindegaard, 2015; Ashley et al., 2005), have been described in 
postoperative horses (Price et al., 2003).  
 
 
Facial expression of pain 
One of the most recent observed behaviour changes in horses during pain is facial expression 
of pain (a so called pain face). Facial expression of pain is considered to be a useful tool in 
pain assessment in the non-verbal human population (e.g. cognitive impairment and neonates) 
(Jordan et al., 2011; Grunau & Craig, 1987). Studies have shown that humans naturally focus 
on the face when assessing pain in humans and animals (Leach et al., 2011; Williamdes, 
2002). Furthermore, studies in humans indicate that facial expression of pain is very hard or 
impossible to fully hide (Prkachin & Mercer, 1989). All this makes facial expression of pain 
an interesting approach in pain assessment in horses. Several different studies regarding facial 
expression of pain related to laboratory animals and rodents have been described. Langford et 
al. (2010) developed the Mouse Grimace scale, consisting of five so called facial action units 
(orbital tightening, nose bulge, cheek bulge, ear position and whisker change) (Langford et 
al., 2010). Later research led to the development of the Rat Grimace Scale (orbital tightening, 
nose/cheek flattering, ear changes, whisker change) and the Rabbit Grimace Scale (orbital 
tightening, cheek flattening, nose shape, whisker position, ear position) (Keating et al., 2012; 
Sotocinal et al., 2011).  
 
Table 1. Description of the features of the equine pain face 
Pain face feature Detailed description 
Asymmetrical/ low ears Both ears are moving in different directions or are placed in 
asymmetrical positions with neither of the ears facing directly 
forward or back. There may be lowering of both ears (increased 
distance between them) with the opening of the ears facing the sides 
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of slightly back. The ears may be both asymmetrical and low. 
Angled eye There is tension of the m. levator anguli occuli medialis 
Withdrawn and tense stare The quality of the glance changes to become withdrawn and tense 
Nostrils – square-like The nostrils are dilated mediolaterally, especially the medial wing of 
the nostril may be tense. This is most obvious during inspiration. 
Tension of the muzzle There is increased tonus of the lips and tension of the chin resulting 
in an edged shape of the muzzle 
Tension of the mimic muscles There is tension of the muscles visible on the lateral aspect of the 
head, especially m. zygomaticus and m. caninus, but m. masseter 
may also be tense 
© 2014 The Authors Veterinary Anaesthesia and Analgesia published by John Wiley & Sons Ltd on 
behalf of Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia 
and Analgesia. Reprinted with permission from Gleerup et al. (2015), An equine pain face. Veterinary 
Anaesthesia and Analgesia, 42: 103–114 under the terms of CC BY-NC-ND 3.0 license 
(http://creativecommons.org/licenses/by-nc-nd/3.0/). Available from: 
http://onlinelibrary.wiley.com/doi/10.1111/vaa.12212/abstract;jsessionid=972521F85677481DF48239
22F5920422.f02t02 
 
Facial expression of pain in equines is recently characterized and described almost 
simultaneously by two different research groups (Dalla Costa et al., 2014; Gleerup et al., 
2015). Dalla Costa et al. (2014) noticed six facial actions units while recording postoperative 
horses that had undergone routine castration, resulting in the Horse Grimace Scale (HGS). 
Their grimace scale involved facial action units; stiffly backwards ears, orbital tightening, 
tension above the eye area, prominent strained chewing muscles, mouth strained and 
pronounced chin and strained nostrils and flattening of the profile. Furthermore, the equine 
pain face is described by Gleerup et al. (2015). They induced noxious somatic stimuli to 
healthy and un-medicated horses while video recording their faces, and then evaluated 
alterations in facial expression during the pain experience. All horses that received noxious 
stimuli showed alterations in facial expressions, even though not all of the identified facial 
action units were present at all times. Gleerup et al. (2015) summarized the facial action units 
involved in the equine pain face as “low and/or asymmetrical ears, an angled appearance of 
the eyes, a withdrawn and/or tense stare, mediolaterally dilated nostrils and tension of the lips, 
chin and certain mimetic muscles” (table 1 and figure 2). The orbital tightening and 
backwards ears observed by Dalla Costa et al. (2014) were associated with horses dozing off 
in the study by Gleerup et al. (2015). Gleerup et al. (2015) therefore suggested that the Horse 
Grimace Scale describes a combination of pain and fatigue due to the surgical stress response. 
Moreover, their study showed that horses did not suppress the facial expression of pain when 
an observer was present but it was less pronounced if the horse tried to interact with the 
observer. 
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Figure 2. (a) Facial expression of a pain free, relaxed and attentive horse (Ill. Andrea Klintbjer). (b) 
Facial expression of a horse in pain, comprising all features of the pain face including asymmetrical 
ears (Ill. Andrea Klintbjer). (c) Facial expression of a horse in pain, comprising all features of the 
pain face including low ears (Ill. Andrea Klintbjer). © 2014 The Authors Veterinary Anaesthesia and 
Analgesia published by John Wiley & Sons Ltd on behalf of Association of Veterinary Anaesthetists 
and the American College of Veterinary Anesthesia and Analgesia. Reprinted with permission from  
Gleerup et al. (2015), An equine pain face. Veterinary Anaesthesia and Analgesia, 42: 103–114 under 
the terms of CC BY-NC-ND 3.0 license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Available 
from:http://onlinelibrary.wiley.com/doi/10.1111/vaa.12212/abstract;jsessionid=972521F85677481D
F4823922F5920422.f02t02. 
 
 
Physiological responses to pain 
Actual or potential threats to an animal (e.g. noxious stimuli) result in well-known stress 
responses, which allow the animal to allocate bodily resources quickly to resolve a problem 
(Wiepkema & Koolhaas, 1993). These stress responses includes changes in the heart rate, 
blood pressure, plasma cortisol and endorphin concentrations. Stress responses are affected by 
many other factors (e.g. fear), and therefore their use as pain indicators is limited when used 
alone (Conzemius et al., 1997). For example induction of anaesthetic/analgesic treatment 
alone has been shown to affect the stress response (Benson et al., 2000; Fox et al., 1994). Use 
of both behavioural and physiological parameters are considered to be more precise than 
physiological parameters alone (Manteca & Deag, 1993).  
 
Heart rate has long been considered to be a good pain indicator in horses, although researches 
have presented diverse results. Certain studies have shown good correlation between 
alteration in heart rate and postoperative pain, acute synovitis and acute somatic pain 
(Lindegaard et al., 2009; Bussières et al., 2008; Pritchett et al., 2003). However, there are 
several studies that show no significant difference in heart rate between control group and the 
group in pain. These studies includes horses with postoperative pain (2011; Sellon et al., 
2004; Price et al., 2003; Raekallio et al., 1997) and acute somatic pain (Gleerup et al., 2015). 
Graubner et al. (2011) stated that “heart rate is sensitive to both internal and environmental 
factors, such as the temperament of the patients, cardiovascular anomalies, stress, excitement, 
medication and ileus”. Another physiological parameter investigated is the respiratory rate. 
Bussieres et al. (2008) managed to show a moderate correlation between respiratory rate and 
acute synovitis pain, but most of the research done is revealing that respiratory rate in not 
correlated or poorly correlated with pain (Gleerup et al., 2015; Graubner et al., 2011; Pader et 
al., 2011; Sellon et al., 2004; Price et al., 2003). Non-invasive systemic arterial blood 
pressure was suggested to be a good potential pain indicator, due to high specificity and 
sensitivity in relation to acute synovitis pain (Bussières et al., 2008). Gleerup et al. (2015) 
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confirmed this by showing that experimentally induced acute somatic pain raised the mean 
arterial blood pressure. Investigations into plasma cortisol concentration as a pain indicator 
have been performed. Like many of the other physiological factors, the outcome of the 
researches differs. Alteration in plasma cortisol concentration has been described to be a good 
pain indicator in horses suffering from postoperative pain (Sellon et al., 2004; Pritchett et al., 
2003) and acute synovitis pain (Bussières et al., 2008). In contrast, Raekallio et al. (1997) 
claimed that plasma cortisol is not a good indicator of postoperative orthopaedic pain in 
horses, since no significant difference was seen between the horses receiving phenylbutazone 
postoperative and the placebo group.  
 
 
Pain scoring scales 
During the last decades several different pain scales have been developed, aimed to assess the 
severity of the pain of the horse. A pain scale should be estimated to its reliability, sensitivity 
and validity (Rutherford, 2002). Streiner et al. (2015) described reliability as “an index of the 
extent to which measurements of individuals obtained under different circumstances yield 
similar result”. To investigate this the same observer is asked to re-score animals on multiple 
occasions (intra-observer reliability) or several observers are asked to score the same animals 
(inter-observer reliability)(Weary et al., 2006). Sensitivity on the other hand is a measure of 
how the parameter changes with changes in the measured quantity (Natelson et al., 1987). 
Finally, validity is described as the extent to which a scale actually measures what it is 
intended to measure (Streiner et al., 2015). 
 
 
Unidimentional scales; VAS, NRS and SDS 
The Visual Analogue Scale (VAS) and the Numerical Rating Scale (NRS) are the two most 
commonly used pain score scales methodologies in humans (Gleerup & Lindegaard, 2015). 
The VAS consists of a 100 mm line, and is marked “no pain” at one end and “the worst 
imaginable pain” on the other end, while the NRS is a scale between 0 and 10. The patients 
decide where to put the marking on the line or scale, to describe the intensity of their pain. 
When applied to horses an observer is asked to decide the pain intensity, consequently relying 
on the observer’s ability to interpret pain behaviours of the horse correctly. Therefore, VAS 
and NRS are well-known to have poor inter-observer reliability (Gleerup & Lindegaard, 
2015). The intra-observer reliability is however good, and the VAS and the NRS can be used 
by the same observer in the same horse over a prolonged time to assess treatment or recovery 
(Hielm-Bjorkman et al., 2011). The sensitivity of the VAS has been discussed, and the 
opinions differ. Some researchers claimed that the VAS has higher sensitivity compared to 
other types of pain scales (e.g. Simple Descriptive Scales) since it is a continuous scale and 
observers do not have to choose between predefined categories (Reid & Nolan, 1991; Scott & 
Huskisson, 1976), while others suggested that the continuous scale gives a false impression of 
having high sensitivity (Holton et al., 1998). Correlation between the VAS and NRS have 
been suggested to be good (Ahlers et al., 2008), while the agreement between the VAS and a 
Composite pain Scale (described later) has only been classified as fair (Lindegaard et al., 
2010). However, several of the studies mentioned above are not executed on horses, which 
should be taken in mind when validating the pain scale (Price et al., 2003).  
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The Simple Descriptive Scale (SDS) consist of description of specific and distinct defined 
indicators of pain, normally ranked from 0 to 4 or 5 (Gleerup & Lindegaard, 2015), dividing 
the pain into absent, mild, moderate or severe (Lerche, 2009). Various researchers have been 
using the SDS when assessing specific types of pain in hoses (Fjordbakk & Haga, 2011; 
Taylor et al., 2002; Jochle et al., 1989). Viñuela-Fernández et al (2011) used a modified 
version of the Obel scale and a clinical grading system, both simple descriptive scales graded 
from 0-4 developed to assess equine lameness, to evaluate clinical laminitis in horses. The 
SDSs used in this study showed overall good reliability. However the inter-observer 
reliability was lower than the intra-observer reliability (Vinuela-Fernandez et al., 2011). The 
general problem with the SDS is that all the numerous pain behaviours that exist are not easily 
fitted into a single five graded scale (Gleerup & Lindegaard, 2015).  
 
 
Composite pain scale 
The Composite (Measure) Pain Scale (CPS/CMPS) is a combination of several different 
SDSs, including specific behavioural or physiological pain indicators, with four or five 
specific defined grades to each indicator (Gleerup & Lindegaard, 2015). Many of the 
behavioural and physiological pain indicators described above are included here. Inter-
observer reliability and validity have been shown to be high when using a CPS (Sutton et al., 
2013; Graubner et al., 2011; Bussières et al., 2008). Bussières et al. (2008) investigated the 
sensitivity of their CPS and found it possible to distinguish three levels of pain, although they 
could only classify the sensitivity as good. Not only the pain indicators included separate 
different CPSs, they also differ in the way of quantifying pain (Gleerup & Lindegaard, 2015). 
Some researchers have been grading all the pain indicators equally (Sutton et al., 2013; 
Bussières et al., 2008), while other have weighted different pain indicators according to its 
significance (Raekallio et al., 1997). The weighted CPM developed by Raekallio et al (1997) 
has served as inspiration to various other CMPs later developed (Gleerup & Lindegaard, 
2015). Gleerup and Lindegaard (2015) recently developed the Equine Pain Scale based on 
previous pain indicator findings, only including the parameters observed to be the most 
reliable in the clinic approach. The Equine Pain Scale is not yet validated.  
 
 
Grimace scale  
A Grimace scale consists of several facial action units observed when the animal experience 
pain (Gleerup et al., 2015; Dalla Costa et al., 2014; Sotocinal et al., 2011). The grimace scale 
has shown good validity when investigated in humans (Langford et al., 2010). Furthermore, 
studies on laboratory animals and rodents have shown that grimace scales have high 
reliability and accuracy (Keating et al., 2012; Sotocinal et al., 2011; Langford et al., 2010). 
The HGS (figure 3) developed by Dalla Costa et al. (2014) showed high inter-observer 
reliability. Dalla Costa et al. (2014) subjectively graded each facial action unit included in the 
HGS as; not present (0), moderately present (1) or obvious present (2), and afterwards the 
total HGS score was calculated. The HGS was well correlated to the CPS also used in the 
study; a high score of the HGS also resulted in a high score of the CPM (Dalla Costa et al., 
2014). However, Gleerup et al. (2015) express the uncertainty whether facial expressions of 
pain are sensitive for grading pain in a quantitative manner. Both Dalla Costa et al. (2014) 
and Gleerup et al. (2015) concluded that facial expression of pain could be a good tool for 
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improving pain assessment in horses, but also suggested further research regarding validity, 
reliability and sensitivity. 
 
 
Figure 3. The Horse grimace Scale with images and explanations for each of the 6 facial action units 
(FAUs). Each FAU is scored according to whether it is not present (score of 0), moderate present 
(score of 1) and obviously present (score of 2).  © 2014 Dalla Costa et al. Originally published in 
Dalla Costa et al. (2014) under the terms of CC by 4.0 license 
(http://creativecommons.org/licenses/by/4.0/). Available from: 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092281.  
 
 
Management of postoperative pain in horses  
Since visceral pain originates from the internal organs (including the gastrointestinal tract) 
and superficial somatic pain originates from the skin (Sjaastad et al., 2010), postoperative 
horses that have undergone a ventral midline exploratory laparotomy suffer from both somatic 
and visceral pain. Horses that have been through abdominal surgery due to acute colic usually 
receive flunixin meglumine (Sellon et al., 2004), which is a nonsteroidal anti-inflammatory 
drug (NSAID). Additional medication after surgery is normally just given to horses that 
express classic behavioural indicators of colic (pawing, flank gestures, rolling ect.). An 
overview of the analgesics most often used to treat pain in horses is given below. 
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Alfa-2 adrenergic drugs 
There are several subclasses of alfa-2 adrenergic agonists. Xylazine and detomidine are the 
two substances licensed for horses and are commonly used for sedation and analgesia 
(Robertson & Sanchez, 2010). Xylazine gives excellent visceral analgesia although it has a 
short duration (up to 90 minutes) (Brunson & Majors, 1987; Muir & Robertson, 1985; 
Kalpravidh et al., 1984b). Muir and Robertson (1985) induced abdominal pain in nine adult 
horses by inflating a balloon in the horses’ cecum and evaluated the analgesic effect of 
xylazine, butorphanol, meperidine and pentazocine. Xylazine was suggested to be the most 
effective analgesic. Transient hypertension and bradycardia, followed by hypotension, are 
described adverse effects associated with xylazine (Clark et al., 1988). Detomidine has also 
been proven to be an effective visceral analgesia (Lowe & Hilfiger, 1986: see Robertson & 
Sanchez, 2010 p. 609). Lowe and Hilfiger (1986) used the cecal balloon distension model and 
found that the duration of action of detomidine was 13.5 minutes at 0.005 mg/kg, 45.5 
minutes at 0.02 mg/kg and 239 minutes at 0.16 mg/kg. This provides the information that the 
analgesic duration of detomidine is dose-dependent. Side effects associated with detomidine 
are ataxia, bradycardia and decreased respiratory rate (Freeman & England, 2000; England et 
al., 1992).  
 
Generally, alfa-2 adrenergic agonists have been shown to decrease the gastrointestinal 
motility and to have a relatively short duration of analgesia provided (Elfenbein et al., 2009; 
Freeman & England, 2001; Doherty et al., 1999; Merritt et al., 1998). This makes the alfa-2 
adrenergic agonists less attractive for pain management in postoperative horses. A 
combination of xylazine and an opioid, such as butorphanol, have been shown to give 
synergetic analgesic effects (Robertson & Muir, 1983), making it possible to reduce the dose 
of xylazine. However, the combination of xylazine and butorphanol prolongs the duration of 
decreased cecal and duodenal activity when compared to only xyalzine given (Merritt et al., 
1998; Rutkowski et al., 1991). Finally, the effect of alfa-2 adrenergic agonists administrated 
as a constant rate infusion (CRI) instead of boluses has not been fully investigated in 
postoperative horses (Robertson & Sanchez, 2010).  
 
 
Nonsteroidal anti-inflammatory drugs 
Nonsteroidal anti-inflammatory drugs (NSAID), acting by inhibit the prostanoid biosynthesis, 
are commonly used for their analgesic and anti-inflammatory effect. NSAIDs can be divided 
into traditional NSAIDs (inhibiting both COX-1 and COX-2) and coxibs (selective COX-2 
inhibitors) (Bruno et al., 2014). The most commonly used NSAIDs in the veterinary practice 
are aspirin, ibuprofen, phenylbutazone, flunixin meglumine, ketoprofen, carprofen, etodolac, 
and meloxicam (Moses & Bertone, 2002). Flunixin meglumine (a traditional NSAID) have 
been shown to provide effective visceral analgesia (Cook et al., 2009), and is suggested to be 
one of the most important and commonly used medication for treatment of visceral pain in 
horses (Robertson & Sanchez, 2010). Flunixin is also proven to reduce lameness and heart 
rate when administrated as a single dose infusion in horses with foot lameness (Foreman et 
al., 2010). Meloxicam (a coxib) has been shown to reduce postoperative pain score in horses 
with experimentally induced ischemic-injured jejunum, when administrated preoperative 
(Little et al., 2007). Furthermore, meloxicam reduced postoperative somatic pain in horses 
that underwent orthopaedic surgery (Walliser et al., 2015). However, postoperative horses 
with small intestine lesions treated with meloxicam (a coxib) have been showed to more often 
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express gross pain signs, compared to horses treated with flunixin meglumine (Naylor et al., 
2014).  
 
Adverse effects in horses associated with NSAID are prevented recovery of ischaemic-injured 
jejunum (Cook et al., 2009; Tomlinson et al., 2004), prolonged permeability defect in 
intestinal mucosa (Tomlinson & Blikslager, 2005), renal crest necrosis, decreased total serum 
protein and albumin concentrations and gastric and colon ulcers (MacAllister et al., 1993). 
However, there are some studies that indicate that traditional NSAIDs and coxibs differ in the 
amount of adverse effects. Tomlinson and Blikslager (2005) showed that deracoxib (a 
selective COX-2 inhibitor) caused no increase in the permeability of the jejunum mucosa in 
contrast to flunixin meglumine (a traditional NSAID), in hosrses with experimentally induced 
ischemid lesion of the jejunum. Furthermore, Cook et al. (2009) showed that the delayed 
mucosal recovery in experimentally induced ischaemic-injured jejunum, present when using 
flunixin meglumine, was not detectable when using firocoxib (a specific COX-2 inhibitor), 
and therefore they suggested that that firocoxib may be useful in horses recovering from 
ishemic-injured jejunum. However, a study containing horses with naturally occurring 
strangulation of the small intestine showed no differences in overall survival, postoperative 
ileus or lipopolysaccharide concentrations between horses treated with meloxicam and 
flunixin meglumine (Naylor et al., 2014).  
 
 
Opioids 
Opioids practice their analgesic effect by acting on specific opioid-receptors throughout the 
body, brain and spinal cord (Kohn & Muir, 1988). There are several different opioids, acting 
on different groups of opioids-receptors (named mu, kappa, sigma and delta) (Kohn & Muir, 
1988) and with different potency (Kalpravidh et al., 1984b). Most of the opioids used in 
horses are µ-agonists (morphine, fentanyl, meperidine, oxymorphone and methadone), or 
mixed agonists/antagonists (butorphanol and pentazocine) (Steven, 1986). Both µ-agonist and 
κ-agonist have been shown to produce dose-dependent analgesia and increased locomotor 
activity (Kamerling et al., 1988; Kamerling et al., 1985). However, µ-agonists also caused 
tachycardia, tachypnea and behavioural arousal (Kamerling et al., 1985) while the κ-agonist 
showed no changes in respiratory rate and heart rate and horses seemed to experience sedation 
rater that arousal (Kamerling et al., 1988). This indicates that different opioids have different 
physiological effects. However, the studies by Kamerling et al. (1985; 1988) are performed on 
healthy horses with experimentally induced pain; therefore the adverse effect of µ-agonists 
and κ-agonist in horses with naturally occurring pain is not investigated.  
 
Butorphanol, a κ-agonist and competitive µ-antagonist, provides good visceral analgesia 
(Kalpravidh et al., 1984b) and have a duration between 15-90 minutes (Kalpravidh et al., 
1984a). However, when administrated as an intravenous bolus adverse effects have been 
observed; such as ataxia, decreased gastrointestinal sounds and decreased defecation (Sellon 
et al., 2001). When butorphanol was administrated as an intravenous CRI ataxia was not 
present and the adverse gastrointestinal effects were less apparent compared to the bolus dose.  
Therefore, Sellon et al. (2001) suggested that butorphanol as a CRI may be a useful treatment 
of pain in horses. Postoperative CRI of butorphanol have been proven to cause significantly 
improved behavior scores in horses during the first 24 hours after celiotomy, thereby 
indicating that the horses experienced less pain (Sellon et al., 2004).  
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Morphine, an example of a µ-agonist, has been shown to provide analgesia in colic horses 
(Phaneuf et al., 1972). Kalpravidh et al. (1984b) investigated the analgesic effects of 
morphine in horses and found that morphine had a good analgesic effect in somatic pain and 
acceptable analgesia for visceral pain. Morphine is associated with adverse effects such as 
decreased gastrointestinal sounds, delayed defecation, promoted fecal drying, and CNS 
excitation (Roberts & Argenzio, 1986). These adverse effects are observed in otherwise 
healthy horses without pain. When given as a CRI morphine was proved to provide analgesia 
in horses with carpal synovitis (Carregaro et al., 2014). However, adverse effects such as 
increased cardiovascular and respiratory parameters and reduced gut sounds were still present.  
 
 
Sodium channel blockers 
Lidocaine is known as local anaesthesia but is commonly administrated as an intravenous CRI 
in horses for its potential analgesic, prokinetic and anti-inflammatory effects (Robertson & 
Sanchez, 2010). Human studies have shown that patients that receive lidocaine as an 
induction bolus and CRI during operation and postoperative, experience less postoperative 
pain, receive prokinetics effects and need a shorter hospitalization (Kaba et al., 2007; 
Groudine et al., 1998; Cassuto et al., 1985).  
 
Few studies are done regarding lidocaine as a potential analgesic in horses. Robertson et al. 
(2005) used a heat element placed on the skin and an intraduodenal and rectal balloon to 
experimentally induce somatic and visceral pain in healthy horses. Horses that received 
intravenous lidocaine showed a higher thermal threshold, suggesting that lidocaine play a role 
in somatic analgesia in horses. However, there was no significant change in tolerance to the 
experimentally induced visceral pain (Robertson et al., 2005). Robertson et al. (2005) discuss 
whether the fact that the study only contained horses with normal gastrointestinal function 
and only one single dose regime could be the reason of the lack of effect. They suggested that 
inflammatory pain and sensitization are probably present in clinical colic, which could 
explain the reported efficacy of lidocaine in those patients. Lidocaine is suggested to have 
anti-inflammatory effects (Nishina et al., 1998; Sasagawa, 1991; Peck et al., 1985), and it is 
possible that lidocaine exert its positive effects through that. Intravenous lidocaine treatment 
have been suggested to reduce the occurrence of postoperative ileus (POI) (Torfs et al., 2009; 
Brianceau et al., 2002) and have positive effects on already existing POI in horses (Malone et 
al., 2006). POI can cause severe pain in postoperative horses, and thereby lidocaine can work 
indirectly as a postoperative analgesic. Adverse effects of lidocaine such as skeletal muscle 
tremors, altered visual function, anxiety, ataxia, collapse and electrocardiographic changes, 
are related to intoxication (Meyer et al., 2001). 
 
 
MATERIALS AND METHODS 
Study design 
The study was designed as an observational case study. Video recording of the horses was 
performed at least 24 hours after surgery to minimize the risk of therapy used before and 
during operation to affect the pain status of the horse on the test day. Each horse was filmed at 
two occasions, directly before receiving analgesic treatment by intravenous infusion and two 
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hours after the analgesic infusion, and thereby acting as its own control. The horse was 
stabled in a box, free to move as it liked, during the whole procedure. The video recordings 
were blinded and randomized by giving each sequence a random number between 1 and 56. 
The sample size first chosen was 20 horses, but due to few incoming colic patient during the 
time data was collected only 12 horses were included. 
 
 
Animals 
Twelve horses that underwent ventral midline exploratory laparotomy or routine castration at 
the university animal hospital in Uppsala (UDS) between May 2015 and October 2015 were 
included in the study. Inclusion criteria for the study required the patient to undergo surgery 
which results in visceral and somatic pain and to receive postoperative analgesic treatment. 
Eleven of the horses included underwent ventral midline exploratory laparotomy due to acute 
colic, and one horse underwent routine castration. Surgical diagnoses of the horses included 
are shown in table 2. Four of the horses that underwent exploratory laparotomy had resection 
of the small intestines and one horse had partial wall resection of the pelvic flexure/right 
dorsal colon. The horse that underwent routine castration was included due to its 
postoperative complications such as internal bleedings and severe pain, which is comparable 
with the pain after exploratory laparatomy.  
 
All horses that underwent exploratory laparotomy received preoperative treatment with 
bensylpenicillin (18-20 mg/kg), gentamicin (6.5-6.6 mg/kg) and flunixin (0.8-1.1 mg/kg), 
except one horse that only received bensylpenicillin and gentamicin. Further, they received 
romifidine (0.05-0.1 mg/kg) and butorphanol 0.02-0.03 mg/kg) as premedication, except one 
horse that just received romifidine. Three of the horses that underwent exploratory 
laparotomy also received acepromazine as premedication (0.02-0.03 mg/kg). The induction 
was carried out by diazepam (0.03-0.04 mg/kg) and ketamine (2.1-2,2 mg/kg) and the 
anaesthesia was maintained with isoflurane. Two horses needed additional medication during 
maintenance and received xylazine (0.1 mg/kg). Futhermore, two of the horses that underwent 
exploratory laparotomy received lidocaine as a bolus dose (2 mg/kg) followed by constant 
rate infusion (2 mg/kg/h) during anaesthesia. One of the horses also received pentobarbital 
(0,009 ml/kg) and romifidin (0.03 mg/kg). The record of the anaesthesia was lost of three of 
the horses that underwent exploratory laparotomy. The horse that underwent routine 
castration received preoperative bensylpenicillin (19 mg/kg) and flunixin (1.1 mg/kg) 
followed by acepromazine (0.03 mg/kg), romifidine (0.1 mg/kg) and butorphanol (0.02 
mg/kg) as premedication. Further, induction was carried out by diazepam (0.03 mg/kg) and 
ketamine (2.2 mg/kg) and the anaesthesia was maintained by isoflurane. Detailed information 
about the horses included, such as age, sex and breed are summarized in table 2. Informed 
owner consent was obtained for each horse. 
 
Table 2. Details of the horses included in the study 
Horse Age 
(years) 
Sex Weight 
(kg) 
Breed Surgical diagnosis 
1 10 Gelding 405 Dutch import Adhesion formation between the cecum, 
abdominal wall and pelvic flexure/ left 
dorsal colon 
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2 4 Mare 421 Warmblood 
trotter 
Small intestinal volvulus 
3 2 Mare 455 Swedish 
warmblood 
Right dorsal displacement, secondary small 
intestinal volvulus 
4 14 Mare 432 Connemara Small intestinal incarceration in greater 
omentum 
5 4 Gelding 506 Swedish 
warmblood 
Left dorsal displacement of the large colon 
6 11 Gelding 438 Warmblood 
trotter 
Resolved strangulation lesion of the small 
intestine 
7 5 Gelding 564 Swedish 
warmblood 
Pedunculated lipoma strangulating the 
small intestine 
8 9 Mare 562 Swedish 
warmblood 
Epiploic foramen entrapment of small 
intestine 
9 11 Gelding 607 Swedish 
warmblood 
Epiploic foramen entrapment of small 
intestine 
10 12 Gelding 216 Shetland pony Large colon torsion and retroflexion 
11 5 Gelding 404 Icelandic 
horse 
Healthy horse  
12 19 Gelding 605 Swedish 
warmblood 
Pedunculated lipoma strangulating the 
small intestine 
 
 
Data collection 
The medical records of the horses included in the study, containing information about 
signalement (age, breed, sex), history of the current episode of colic, physical examination 
during hospitalization, laboratory results, clinical diagnosis and treatment of the patient 
(performed surgery, date of the surgery, surgical diagnosis including disease location), and 
medical therapy (anaesthesia, analgesia and postoperative treatment), were compiled into an 
Excel file and analysed using Excel and Minitab. The analgesic treatment at the time of film 
recording for each horse is summarised in table 3.  
 
Table 3. Analgesic treatment of the included horses at the time of film recording 
Horse 
Film 
occasion 
Analgesic treatment 
1 1 Lidocaine CRI 3 mg/kg/day 
 2 Lidocaine CRI 3 mg/kg/h, flunixin 1.1 mg/kg 1 time/day  
2 1 None 
 2 Flunixin 1.1 mg/kg 1 time/day 
3 1 None 
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 2 Flunixin 1.1 mg/kg 1 time/day 
4 1 Lidocaine CRI 3 mg/kg/h 
 2 Lidocaine CRI 3 mg/kg/h, flunixin 1 mg/kg 1 time/day 
5 1 None 
 2 Flunixin 1.1 mg/kg 1 time/day 
6 1 None 
 2 Flunixin 1.1 mg/kg 2 times/day 
7 1 Flunixin 1.1 mg/kg 1 times/day 
 2 
Detomidine 0.007 mg/kg, butorphanol bolus 0.02 mg/kg + butorphanol CRI 
12.5 mg/kg/h 
8 1 Lidocaine CRI 3 mg/kg/h 
 2 Lidocaine CRI 3 mg/kg/h, flunixin 1.1 mg/kg 2 times/day 
9 1 Lidocaine CRI 3 mg/kg/h 
 2 Lidocaine CRI 3 mg/kg/h, flunixin 1 mg/kg 2 times/day 
10 1 Lidocaine CRI 3 mg/kg/h 
 2 Lidocaine CRI 3 mg/kg/h, flunixin 1.2 mg/kg 2 times/day 
11 1 Butorphanol CRI 0.025 mg/kg/h 
 2 Butorphanol CRI 0.025 mg/kg/h, flunixin 1 mg/kg 1 time/day 
12 1 Lidocaine CRI 3 mg/kg/h 
 2 Lidocaine CRI 3 mg/kg/h, flunixin 1.1 mg/kg 2 times/day 
 
 
Video recordings 
The video recording was performed by a single person (the author) using a pocket type digital 
camera and a tripod. Disturbance of the horse during the procedure attempted to be avoided 
by working quietly and when possibly stand out of the view of the horse. The tripod with its 
camera was placed outside the box, approximately 1.5-2 meters from the box. The horse and 
its behaviour were filmed from this view for 2 minutes. After two minutes the person walked 
towards the door of the box, opened it and offered the horse a small piece of an apple by 
reaching out the hand and not making eye contact, and thereby recording the interactive 
behaviour and response to food. The whole procedure was filmed by the camera on the tripod. 
The camera was then removed from the tripod to enable a close up filming of the face of the 
horse. The halter was removed from the horse before filming the face. The camera was held 
so that the camera caught the whole face of the horse for at least two minutes if possible. A 
label with the name and journal number of the horse and a watch were filmed to be able to 
connect the film with the correct medical journal, time and date. This whole procedure was 
repeated when filming the horse two hours after analgesia administration. 
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Video editing 
Both films of each horse, one before treatment and one after treatment, were cut down to three 
different film sequences by using Camtasia studio 8 ® software. The first sequence contained 
a 90 seconds long film involving the horse viewed from outside the box, evaluation of its 
interactive behaviour and its response to food. The film sequence selection and editing was 
made so that the sequence represented the behaviour of the horse of the full time film. 
Consequently, if the horse showed signs of pain only half of the time filming, both normal 
behaviour and pain behaviour must be included in the final sequence. The second sequence 
contained a 2 minutes long close up film of the face of the horse. The third sequence 
contained 30 seconds close up film of the face of the horse, the best part of sequence number 
two. The film clips of the face included were subjectively chosen by a single non-blinded 
person. This non-blinded person subjectively selected a sequence that involved as many facial 
action units of the equine pain face as possible. To be selected the film sequence also had to 
be of good quality. In a few cases it was not possible to film the face of the horse for 2 
minutes (horse refused to stand still), and the recorded film therefore were put on repeat to 
receive the 2 minute sequence.  
 
All the film sequences were first put into two different PowerPoint presentations, the 90 
seconds clips in the first PowerPoint presentation and the 2 minutes clips and 30 seconds clips 
of the horses’ faces in the second PowerPoint presentation. Each film clip was inserted at a 
separate slide in the PowerPoint presentation, in a randomized order. The randomisation was 
carried out by using a list randomizer at a website. Eight of the twelve horses included in the 
study were selected randomly by using the randomizer list. To be able to evaluate the intra-
observer reliability the 2 minute clip before analgesic treatment of each selected horse were 
chosen to be inserted two times in the second PowerPoint presentation. 
A third PowerPoint presentation was made, containing only the 30 seconds clips of the 
horses’ faces. Each horse, before and after treatment, was inserted on a separate slide in a 
randomised order inside the slide, and labelled with the letters A and B.  
 
Observer blinded pain scoring 
 
Table 4. Modified version of the Equine pain scale 
Behaviour 
category 
       Score   
0 1 2 3 4 
Gross pain 
behaviour* 
None  Occasional  Continuous 
Activity Exploring 
attention 
towards the 
surroundings 
or resting 
No movement  Restless Depressed 
Location in the 
stall 
At the door 
watching the 
environment 
Standing in the 
middle, facing 
the door 
Standing in the 
middle facing 
the sides 
Standing in the 
middle facing 
back or 
standing in the 
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back 
Posture/weight 
bearing 
Normal 
posture and 
normal weight 
bearing 
Foot 
intermittent of 
the ground/ 
occasional 
weight shift 
 Continuously 
taking foot off 
the ground and 
trying to 
replace it. 
No weight 
bearing. 
Abnormal 
weight 
distribution 
Head position Foraging, 
below withers 
or high 
Level of 
withers 
Below withers   
Attention 
towards the 
painful area 
Does not pay 
attention to 
painful area 
 Brief attention 
to painful area 
(e.g. flank 
watching) 
 Biting, 
nudging or 
looking at 
painful area 
(e.g. flank 
watching) 
Interactive 
behaviour 
Looks at 
observer or 
moves to 
observer when 
approached 
Looks at 
observer does 
not move 
Does not look 
at observer or 
moves away 
avoids contact 
Does not 
move, not 
reacting/ 
introverted 
 
Response to 
food 
Takes food 
with no 
hesitation 
Looks at food  No response to 
food 
 
*Gross pain behaviour includes all readily visible behaviours like, excessive head movements 
(vertical/lateral), flehmen, kicking, pawing, rolling, tail swishing, mouth playing, repeated stretching, 
etc. © 2015 EVJ Ltd. Adapted with permission from Gleerup, K.B. & Lindegaard, C. (2015), 
Recognition and quantification of pain in horses: A tutorial review. Equine Veterinary Education. doi: 
10.1111/eve.12383. Published online by Wiley Online Library. 
 
The two first PowerPoint presentations were shown to two different groups of blinded 
observers; a group of veterinarians consisting of three individuals and a group of veterinary 
students consisting of four individuals. The three veterinarians had a large experience of pain 
assessment in horses by evaluating facial expression. The students, which did not have any 
experience of pain assessment in horses by facial expression, received a 30 minutes long 
introduction, given by the author, about facial expression of pain in horses just before they 
watched the movies of the faces of the horses. The PowerPoint presentation containing the 90 
seconds clips were shown the first day. The observers were asked to pain score the horses 
included by using the modified version of the Equine Pain Scale (pain face category and 
“pinched” alternative excluded, hereafter called the modified EPS) (table 4). Each clip was 
shown only ones. If the observers were not able to assess a certain category (e.g. due to 
obscuring view) they were asked to draw a line in the box.  
 
At the second day the PowerPoint containing the 2 minutes clips and 30 seconds clips were 
shown to the same observers, who were asked to grade the facial expression of each horse in 
“no pain face”, “pain face present” or “intense pain face”. Each film sequence was shown 
only ones and the observers had to choose an answer to each horse. The veterinarians were 
also asked to motivate what they were basing their quantitative assessment of the pain face 
on. The veterinary students, after receiving their introduction about facial expressions of pain 
19 
 
in horses, were asked to grade the facial expression of pain in the categories mention above 
by using Turning point ResponsCards.  
 
The third PowerPoint presentation was shown to a new group of observers (6 veterinarians).  
They were asked to tell which of the horses on the same slide that was in most pain, or if the 
horses were in same grade of pain. Observers were allowed to play the film sequences as 
many times they wanted.  
 
 
Statistical analysis 
Minitab 17 ® statistical software was used to perform the statistical analysis. Fleiss’ kappa 
was used to calculate inter- and intra-observer reliability of the grading of facial expression of 
pain. Interpretation of the kappa values was based on a table suggested by Landis and Koch 
(1997). Since both experienced and inexperienced observers were shown the film sequences 
the differences in inter- and intra-observer reliability was evaluated.  
 
Only observers with an intra-observer reliability of facial expression of pain with the kappa 
value of 0.5 or more were selected (five observers) to represent further investigations, since 
they were appraised to have a more reliable way of grading facial expression of pain. The 
sensitivity of facial expression of pain was investigated by comparing the medians of facial 
expression of pain with the median scores of the modified EPS, and also by evaluating the 
inter-observer reliability of each grading category of facial expression of pain. Correlation 
between grading of facial expression of pain and the score of the modified EPS was 
calculated, using Kendall´s tau-b. 
 
To investigate the hypothesis of this study the median score of facial expresses of pain and the 
median score of the modified EPS were compared within each horse before and after 
analgesic treatment. A paired t sample test was performed of the modified EPS score before 
and after treatment. Furthermore, Fisher’s exact test was calculated for grading of facial 
expression of pain (no pain face, pain face present) before and after treatment.  
 
To investigate if it is possible to see facial expressions of pain after watching the face for just 
30 seconds, Fleiss kappa was used to compare the agreement between the 30 seconds clips ad 
2 minutes clips. The effect of the lidocaine and butorphanol hangover treatment was 
investigated regarding the proportion of present pain face and agreement between observers. 
Only the results of observers with a kappa value of intra-observer reliability above 0.5 was 
included. Agreement was calculated by counting the proportion of observers agreeing with 
the median value of the grading of facial expression of pain in each horse. Finally, inter-
observer reliability was also calculated of the observers who graded which horse that was in 
most pain (the third PowerPoint presentation). 
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RESULTS 
Facial expression of pain 
Inter-observer reliability 
The kappa value of the overall inter-observer reliability of grading facial expression of pain 
for all observers was determined to 0.11 (slight agreement) when three categories were used 
to grade the facial expression of pain (no pain face, pain face present, intense pain face). An 
increase of the kappa value to 0.22 (fair agreement) was seen when only two categories were 
used in the grading (no pain face, pain face present). Both inexperienced and experienced 
observers increased their inter-observer reliability when only two categories were used to 
grade facial expression of pain. Observers agreed in a higher amount of the horses that 
showed no pain face or intense pain face, compared to when horses just expressed a present 
pain face. The kappa values of each category are shown in table 5. Experienced observers had 
a higher agreement of the category intense pain face (kappa value 0.22) compared to 
inexperienced observers (kappa value 0.04) and experienced observers stated to base their 
quantitative assessment on the number of visible facial action units and the overall 
impression.   
 
Table 5. Inter-observer reliability of observers grading the facial expression of pain 
Grading Kappa  SE Kappa Grading Kappa SE Kappa 
No pain face 0.218973 0.0291606 No pain face 0.218973 0.0291606 
Pain face present 0.025588 0.0291606 Pain face present 0.218973 0.0291606 
Intense pain face 0.105886 0.0291606    
Overall 0.112651 0.0216156 Overall 0.218973 0.0291606 
 
The inter-observer reliability was also calculated of the observers grading which horse that 
was in most pain (third PowerPoint presentation). The overall kappa value was determined to 
0.48 (moderate agreement) (see table 5).  
 
Table 6. Inter-observer reliability of observers grading which horse that was in most pain 
Which horse is in most pain? Kappa SE Kappa 
Horse before treatment 0.541259 0.0745356 
Horse after treatment 0.444444 0.0745356 
Both are in the same pain 0.373913 0.0745356 
Overall 0.483871 0.0667585 
 
 
Intra-observer reliability 
The mean kappa value of all observers was determined to 0.51 (moderate agreement). The 
kappa values of the inexperienced observers varied and were determined to -0.33 (poor 
agreement), 0.53 (moderate agreement), 0.71 (substantial agreement) and 0.77 (substantial 
agreement). The mean kappa value of the inexperienced observers was 0.42 (moderate 
agreement).The experienced observers had the following kappa values; 0.37 (fair agreement), 
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0.51 (moderate agreement) and 1 (perfect agreement). This gave a mean kappa value of 0.63 
(substantial agreement).The intra-observer reliability is summarized in table 7. 
 
Table 7. Kappa values of intra-observer reliability 
Observers 
                           Inexperienced                 Experienced 
Kappa Interpretation Kappa Interpretation 
-0.333333 Poor agreement 0.372549 Fair agreement 
0.52941 Moderate agreement 0.507692 Moderate agreement 
0.709091 Substantial agreement 1 Perfect agreement 
0.76812 Substantial agreement   
Mean kappa 0.42 Mean kappa 0.63 
 
 
Agreement between the 30 seconds clips and the 2 minutes clips 
The median of facial expression of pain of the 30 seconds clips and 2 minutes clips were used 
to calculate Fleiss’ kappa. Agreement between the 30 seconds clips and the 2 minutes clips 
was determined to 71%, with an overall kappa value of 0.44.  
 
 
Effect of analgesic treatment 
The analgesic treatment by time of the film occasions differs between the horses (see table 3). 
To investigate how the lidocaine and butorphanol hangover treatment affect the grading of 
facial expression of pain the proportion of expressed facial expression of pain and agreement 
between observers in the different treatment groups was calculated (see table 8).    
 
Table 8. The effect of lidocaine and butorphanol treatment on proportion of present pain face and 
agreement between observers. Based on the assessment by observers with an kappa value of intra-
observer reliability  above 0.5                                     
Horse Film occasion Grading of pain face Agreement 
No lidocaine/butorphanol    
2 1 Present 80% 
 2 No 100% 
3 1 Present 80% 
 2 Present 60% 
5 1 Present 80% 
 2 No 100% 
6 1 No 60% 
 2 Present 60% 
7 1 Present 100% 
  Proportion pain face: 67% Mean agreement: 80% 
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Lidocaine    
1 1 No 60% 
 2 Present 60% 
4 1 Present 80% 
 2 Present 100% 
8 1 No 60% 
 2 Present 40% 
9 1 Present 60% 
 2 Intense 60% 
10 1 Present 100% 
 2 Present 60% 
12 1 Intense 60% 
 2 No 60% 
  Proportion pain face: 75% Mean agreement: 67% 
Butorphanol    
7 2 No 60% 
11 1 Present 40% 
 2 Present 60% 
  Proportion pain face: 67% Mean agreement: 53% 
 
To decide whether the horses expressed facial expression of pain the median of grading of 
facial expression of pain, by the observers with a kappa value of intra-observer reliability 
above 0.5, was calculated for each horse before and after treatment. Nine out of twelve horses 
included in the study expressed facial expression of pain before analgesic treatment. Of these 
horses, four did not express facial expression of pain after analgesic treatment and five horses 
did not show any changes in grading of facial expression of pain. Three of the horses included 
in the study showed no facial expression of pain before analgesic treatment but in contrast the 
expressed it after analgesic treatment. The distribution of the horses is shown in table 9. No 
significant difference could be seen in presence of facial expression of pain before and after 
analgesic treatment when Fisher’s exact test was calculated (p-value = 0.68). 
 
Table 9. Cross-tabulation of grading of facial expression of pain before and after analgesic treatment 
 After treatment 
Before treatment No pain face Pain face present Intense pain face 
No pain face 0 3 0 
Pain face present 3 4 1 
Intense pain face 1 0 0 
 
 
23 
 
The equine pain scale 
Effect of analgesic treatment 
 
Figure 3. Boxplot of the Equine Pain Scale score before and after treatment, decided by the observers 
with an intra-observer reliability kappa value over 0.5. 
 
The pain score assessment of each horse before and after analgesic treatment, made by 
observers with a kappa value above 0.5, is presented in figure 3. The median values of the 
score of the modified EPS were calculated for each horse (before and after analgesic 
treatment), to be able to compare the score before and after treatment. Analgesic treatment 
caused a decrease in pain score in 50% of the horses, an increase in pain score in 33% of the 
horses and no difference in pain score in 17% of the horses. However, no significant 
difference could be seen in pain score before and after analgesic treatment. 
 
 
Relationship between facial expression of pain and the Equine Pain Scale  
The total pain score of the Equine Pain Scale was divided into three different groups by using 
the boxplot of pain score. Group 1 consisted of median pain score of 0-3, group 2 consisted of 
median pain score of 4-7, and group 3 consisted of median pain score of 8-11. These groups 
of horses were compared to the grading of facial expression of pain. 63% of the horses in 
group 1 expressed a pain face and 60% of the horses in group 2 expressed a pain face. 
Furthermore, 100% of the horses in group 3 expressed a pain face. Kendall´s Tau-b was 
determined to 0.3 when facial expression of pain (no pain face, pain face present and intense 
pain face) was compared to the Equine Pain Scale score (group 1, 2 and 3).  
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DISCUSSION 
Study design 
This study evaluates the clinical application and usefulness of facial expression of pain as a 
pain assessment tool in postoperative horses. Facial expression of pain has earlier been 
described in horses with experimentally induced somatic pain and in horses after routine 
castration (Gleerup et al., 2015; Dalla Costa et al., 2014), but the facial action units described 
differs slightly between the studies. For this study the equine pain face described by Gleerup 
et al. (2015) was assumed to be the most reliable, since the HGS described by Dalla Costa et 
al (2014) is suggested to be a combination of fatigue and pain (Gleerup et al., 2015).  
Reference population of this study unit aims to be postoperative hospitalised horses with 
combined visceral and somatic pain.  
 
Previous studies of facial expression of pain in horses have been performed during more 
controlled and experimental conditions. Dalla costa et al (2014) used two high definition 
cameras placed at opposite sides of the box, which enabled capturing of high quality videos 
and still images. Furthermore, the horses in the study by Gleerup et al (2015) were filmed 
while they were fixated by a neck collar and with a bright background of the face to make the 
facial expression more visible. In the present study, performed to resemble the clinical 
practice, horses were not fixated during filming of the face and the light was not always 
optimal to capturing the subtle changes in facial expression. Other factors that may have 
contributed to a more difficult assessment of facial expression of pain compared to previous 
studies are the fact that 3 of the horses included received skin lesion and swellings around the 
eyes during anaesthesia induction, one of the horses received postoperative toxinemia and 
secondary oedema of the face and one horse had underwent a pinna resection of the left ear. 
Some specific horses in the present study (horse five and six) were classified by the 
experienced observers as hard to evaluate or to have a sedated look. Horse five continuously 
moved its head during the film recording and horse six was one of the horses with skin lesions 
and swellings around the eyes. This shows the difficulties and variation in the ability to 
correctly assess facial expression of pain in the clinical practice. 
 
A newly publish study has proven that isoflurane anaesthesia alone increase the score of the 
Mice Grimace Scale (Miller et al., 2015). However, in the study pain assessment was 
performed only 30 minutes after anaesthesia. All horses included in the present study were 
filmed at least 24 hours after surgery. Therefore the medical therapy used during anaesthesia 
should not be able to interfere with the pain assessment.  
 
A modified version of the EPS was used to pain score all the included horses. The observer 
should pain score the horse in a quiet environment, without interacting or disturbing the horse, 
to make sure that the horse does not hide its pain behaviours. In an equine practice this in not 
always possible. There are a lot of persons working at the clinic and there are often several 
different horses in each stall, consequently there will be interaction and noises around the 
horses. Furthermore, the observer needs to stand relatively close to the box to be able to 
assess the pain behaviours of the horse. Therefore, it is possible that the horses in the present 
study hid some of their pain behaviours and that the pain score is lower than it would be in an 
optimum environment. However, the environment in the study is realistic and therefore the 
clinical application of the modified EPS is evaluated. The category “posture/ weight bearing” 
was hard to evaluate in several video films due to the horse was standing behind the box wall, 
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making it harder to notice weight shifting. This indicates that the category “posture/weight 
bearing” sometimes is hard to evaluate in the clinical practice, and that horses may get a lower 
score of the modified EPS than they would with experimental conditions.  
 
 
Effect of analgesic treatment 
All of the 12 horses included in the present study showed facial expression of pain, either 
before or after analgesic treatment, or by both film occasions. The hypothesis was that facial 
expression of pain in postoperative horses would disappear or diminish after pain medication. 
However, there was no significant difference of either facial expression of pain or score of the 
modified EPS before and after treatment. Only 4 of the 9 horses that expressed facial 
expression of pain before treatment responded to the analgesic treatment by not expressing 
facial expression of pain. Consequently, 5 of the horses continued to exhibit facial expression 
of pain after analgesic treatment. The reason could be that the analgesic treatment given was 
not enough to give full-scale analgesia, and therefore the horses were in pain in both film 
occasions. In the present study the number of expressed facial action units of the equine pain 
face was not evaluated. Therefore, the possibility that these five horses expressed fewer facial 
action units after the analgesic treatment cannot be rejected. Another possible reason for 
horses expressing facial expression of pain after analgesic treatment could be that other 
conditions than pain can cause changes in the facial mimic of the horse. It is common 
knowledge that human beings express not only facial expression of pain but also change their 
facial mimic when they experience nausea, distress, excitement, fear etc. However, these 
conditions have not yet been investigated regarding facial expressions in horses. Therefore, 
the specificity of facial expression of pain in horses can be questioned.  
 
The fact that six of the horses included were put on a CRI of lidocaine and one horse received 
CRI of butorphanol, during both film occasions should be taken into account. Lidocaine has 
been proven to reduce somatic pain and inflammation (Nishina et al., 1998; Sasagawa, 1991; 
Peck et al., 1985) and butorphanol provides good visceral analgesia (Kalpravidh et al., 
1984b). Consequently, the hangover treatment with lidocaine and butorphanol could have 
contributed to a lower grade of pain in the horses, both before and after the analgesic 
treatment, further contributing to the non-significant difference before and after treatment in 
grading of facial expression of pain and score of the modified EPS. However, horses that did 
not receive CRI of lidocaine or butorphanol did not show a significant difference before and 
after treatment either.  
 
 
Reliability 
The inter-observer reliability of grading of facial expression of pain has previously been 
described as high when used as a grimace scale, with an overall Intraclass Correlation 
Coefficient value of 0.92 (Dalla Costa et al., 2014). In this present study Fleiss kappa was 
used to calculate the reliability, therefore the numbers between the studies should not be 
compared directly. However, in the present study there was only slight agreement between the 
observers, with a kappa value of 0.11 when the grading consisted of three categories and 0.22 
when only two categories are used. The low agreement between observers is suggested to 
depend on several things, such as differences in the subjective grading of a so called pain face 
between observers, the overhanging treatment with lidocaine and butorphanol and the 
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differences between individuals’ ability of grading facial expression of pain. In this present 
study the observers were asked to grade the facial expression of pain subjectively, without a 
definition of the two “pain face present” or “intense pain face”. This is most likely the reason 
for the low inter-observer reliability. By using a grading system for each facial action unit, as 
in the study by Dalla Costa et al (2014), the assessment gets more objective.  
 
Low doses of lidocaine are described as sedating in some anesthesiology handbooks (Doherty 
& Valverde, 2006), and κ-agonists cause sedation in healthy horses (Kamerling et al., 1988). 
Therefore, it is possible that the lidocaine and butorphanol treatment could have caused 
changes in the facial mimic, making it harder to evaluate facial expression of pain. Treatment 
with lidocaine or butorphanol is suggested to contribute to a lower inter-observer reliability, 
since the agreement of grading of facial expression of pain between observers was lower in 
the groups of horses treated with lidocaine or butorphanol (see table 8). 
 
Furthermore, horses included in the present study were suffering from visceral and somatic 
pain. The equine pain face was described in horses with experimentally induced somatic pain 
(Gleerup et al., 2015). It is possible that horses experiencing visceral pain express a different 
kind of pain face, which could be an additional reason for the low inter-observer reliability. 
 
Inter-observer reliability was also calculated of observers choosing which horse that was in 
most pain (horse before treatment, horse after treatment or same level of both). Following the 
pain level of a horse in analgesic treatment is an important and ordinary task in the clinical 
practice. An increase of the kappa value to 0.48 was seen, indicating that facial expression of 
pain is easier to grade when compared when compared within a horse by different occasions.  
 
The intra-observer reliability varied between the observers, suggesting that there are 
individual variations in the ability to evaluate facial expressions of pain. However, 5 out of 7 
observers had a kappa value above 0.5 which is considered as moderate agreement. The 
differences in itra-observer reliability between inexperienced and experiences observers 
suggest that experienced individuals have a better capacity of grading facial expression of 
pain. Still, the relatively high kappa values of the inexperienced observers suggest that it is 
possible to learn the basics of assessment of facial expression of pain after only a short 
introduction. Statistical analysis of the reliability of facial expression of pain in horses 
suggests that it could be a valuable assessment tool when the same person follows the pain 
status of the same patient over a time, for example if a treating veterinarian wants to follow 
the recovery of a horse.  
 
 
Sensitivity 
The ability to grade pain in a quantitative manner by using facial expression of pain have been 
questioned (Gleerup et al., 2015). In this study the observers were asked to subjectively grade 
the facial expression of pain in “no pain face”, “pain face present” or “intense pain face”. The 
kappa value of the alternative “pain face present” was determined to 0,03 and the kappa value 
of the alternative “intense pain face” was determined to 0,11 when investigating the inter-
observer reliability. These results suggest that facial expression of pain is a more reliable tool 
when the horse has an intense pain face, but it is easy to miss a mild or moderate pain face. 
Dalla Costa et al (2014) showed that horses with high pain score of a Composite Pain Scale 
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also received high HGS score, suggesting that the number of facial action units of the equine 
pain face represent the amount of pain. However, no study has been done regarding the 
signification of each facial action unit of the equine pain face. A weighting of the facial action 
units would be of great interest to be able to correctly quantify the pain by facial expression.  
 
A comparison was made between the Equine Pain Scale score and grading of facial 
expression of pain. Facial expression of pain was shown by horses with very different pain 
score, including horses with pain score of 0. Several different factors influence the pain 
experience and expression, such as breed, individual variation, environment characteristics 
and drugs (Flecknell, 2000: see Bussières et al., 2008). Furthermore, horses are prey animals 
and may hide some of their pain behaviours. However in humans, facial expression of pain 
has been proven impossible to fully hide (Prkachin & Mercer, 1989). In theory this makes 
facial expression of pain a more reliable pain assessment tool in the clinical practice, 
compared to other pain behaviour based scales.  
 
In this present study, five horses with a low pain score of 0-3 expressed a so called pain face. 
This could indicate that facial expression of pain has a higher sensitivity than the Equine Pain 
Scale when used in the clinical practice. Still, four horses with a pain score of 6-7 did not 
express facial expression of pain. These four horses were all difficult to judge due to heavy 
head movement, bad quality of video recording, swollen eyes of the horse and horse 
temperament. However, it is impossible to say whether these horses actually experienced pain 
or not. Furthermore, the Equine Pain Scale is not validated and the sensitivity of the scale is 
not determined. Therefore, the sensitivity of facial expression of pain in hard to evaluate in 
this present study. All horses with a pain score of 8 and above expressed facial expression of 
pain. This could indicate that facial expression of pain is more reliable in horses with a higher 
grade of pain, or that those horses below pain score of 8 are not always in pain.  
 
 
CONCLUSION  
Facial expression of pain was observed in all of the 12 horses included in the present study. 
However, no significant difference in grading of facial expression of pain or pain score before 
and after analgesic treatment could be seen. This indicates that the analgesic treatment was 
not always optimized or that there are several other conditions present that caused changes in 
the face mimic in horses. Evaluation of the reliability of the grading of facial expression of 
pain suggests that evaluation of pain face could be a good supplementary pain assessment tool 
when a single person follows a patient over a time. A definition of the equine pain face 
regarding the amount of present facial action units needed and weighting of the facial action 
units is of great interest in order to create a higher inter-observer reliability. A comparison 
between the grading of facial expression of pain and the Equine Pain Scale score showed that 
all horses with a pain score of 8 and above showed facial expression of pain. Further studies 
regarding the specificity and sensitivity of facial expressions of pain are required.  
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